| DIRECT COMPETITOR COMPARISON | |
| ENMD | Pvt1 | Pvt2 | PGLA | Industry | | Market Cap: | 82.50M | N/A | N/A | N/A | 104.07M | | Employees: | 21 | 11,1741 | N/A | N/A | 68 | | Qtrly Rev Growth (yoy): | 4.80% | N/A | N/A | N/A | 19.70% | | Revenue (ttm): | 7.64M | 13.42B1 | N/A | N/A | 14.01M | | Gross Margin (ttm): | 100.00% | N/A | N/A | N/A | 65.67% | | EBITDA (ttm): | -5.37M | N/A | N/A | N/A | -12.30M | | Oper Margins (ttm): | -72.16% | N/A | N/A | N/A | -149.46% | | Net Income (ttm): | -10.04M | N/A | N/A | N/A | N/A | | EPS (ttm): | -0.114 | N/A | N/A | N/A | -0.33 | | P/E (ttm): | N/A | N/A | N/A | N/A | 16.37 | | PEG (5 yr expected): | N/A | N/A | N/A | N/A | 1.31 | | P/S (ttm): | 10.91 | N/A | N/A | N/A | 9.43 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.69 | 0.60% | 57.38B | 12.36 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.44 | 1.07% | 13.72B | 15.88 | | Genzyme Corp. | GENZ | 51.35 | 1.28% | 13.63B | 29.28 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 45.985 | -0.27% | 41.38B | 17.78 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.99 | 2.43% | 9.09B | 1040.61 | | Teva Pharmaceutical Industries Limited | TEVA | 53.26 | 0.89% | 46.92B | 48.73 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.47 | 1.02% | 3.98B | 19.31 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.805 | -0.21% | 2.93B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.18 | 1.73% | 5.56B | 111.53 | | Pfizer Inc. | PFE | 18.67 | 2.75% | 150.66B | 15.51 | | Johnson & Johnson | JNJ | 63.35 | 0.81% | 174.79B | 13.83 | | GlaxoSmithKline plc | GSK | 42.41 | 2.27% | 107.51B | 13.46 | | Sanofi-Aventis | SNY | 39.14 | 3.11% | 102.20B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 56.15 | 0.99% | 127.53B | 16.81 | | RHHBY.PK | 41.46 | 1.32% | N/A | N/A | | AstraZeneca plc | AZN | 45.58 | 1.67% | 66.09B | 9.15 | | Abbott Laboratories | ABT | 54.33 | -0.29% | 84.03B | 14.72 | | Bristol-Myers Squibb Co. | BMY | 24.72 | -2.33% | 48.97B | 12.79 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|